Belite Bio, Inc Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Belite Bio, Inc (BLTE) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.47 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-03-31
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | 7.47M shares 20-F · filed 2026-03-31 | |
| 2024-12-31 | 6.01M shares 20-F · filed 2026-03-31 | |
| 2023-12-31 | 5.18M shares 20-F · filed 2026-03-31 | 5.16M shares 20-F · filed 2024-03-12 |
| 2022-12-31 | 3.75M shares 20-F · filed 2025-03-17 | 3.58M shares 20-F · filed 2023-03-31 |
| 2021-12-31 | 9.80M shares 20-F · filed 2024-03-12 | |
| 2020-12-31 | 11.22M shares 20-F · filed 2023-03-31 |